annual operating expenses:
$604.83M+$177.39M(+41.50%)Summary
- As of today (May 30, 2025), AXSM annual total operating expenses is $604.83 million, with the most recent change of +$177.39 million (+41.50%) on December 31, 2024.
- During the last 3 years, AXSM annual operating expenses has risen by +$480.12 million (+385.00%).
- AXSM annual operating expenses is now at all-time high.
Performance
AXSM Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$167.14M-$2.74M(-1.61%)Summary
- As of today (May 30, 2025), AXSM quarterly total operating expenses is $167.14 million, with the most recent change of -$2.74 million (-1.61%) on March 31, 2025.
- Over the past year, AXSM quarterly operating expenses has increased by +$29.75 million (+21.66%).
- AXSM quarterly operating expenses is now -1.61% below its all-time high of $169.88 million, reached on December 31, 2024.
Performance
AXSM quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AXSM Operating expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +41.5% | +21.7% |
3 y3 years | +385.0% | +336.5% |
5 y5 years | +801.3% | +414.4% |
AXSM Operating expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +385.0% | -1.6% | +336.5% |
5 y | 5-year | at high | +801.3% | -1.6% | +840.1% |
alltime | all time | at high | >+9999.0% | -1.6% | +9751.1% |
AXSM Operating expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $167.14M(-1.6%) |
Dec 2024 | $604.83M(+41.5%) | $169.88M(+19.2%) |
Sep 2024 | - | $142.56M(-8.0%) |
Jun 2024 | - | $155.00M(+12.8%) |
Mar 2024 | - | $137.39M(+15.2%) |
Dec 2023 | $427.44M(+93.1%) | $119.22M(+5.0%) |
Sep 2023 | - | $113.56M(+12.3%) |
Jun 2023 | - | $101.11M(+8.1%) |
Mar 2023 | - | $93.56M(+20.3%) |
Dec 2022 | $221.34M(+77.5%) | $77.80M(+35.6%) |
Sep 2022 | - | $57.38M(+19.8%) |
Jun 2022 | - | $47.88M(+25.0%) |
Mar 2022 | - | $38.29M(+17.4%) |
Dec 2021 | $124.71M(+25.9%) | $32.61M(-2.4%) |
Sep 2021 | - | $33.41M(+8.3%) |
Jun 2021 | - | $30.85M(+10.8%) |
Mar 2021 | - | $27.84M(+0.6%) |
Dec 2020 | $99.09M(+47.7%) | $27.69M(+31.1%) |
Sep 2020 | - | $21.13M(+18.8%) |
Jun 2020 | - | $17.78M(-45.3%) |
Mar 2020 | - | $32.49M(+33.0%) |
Dec 2019 | $67.11M | $24.43M(+29.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $18.81M(+39.9%) |
Jun 2019 | - | $13.45M(+29.0%) |
Mar 2019 | - | $10.42M(+10.3%) |
Dec 2018 | $32.63M(+21.0%) | $9.45M(+17.7%) |
Sep 2018 | - | $8.03M(+0.5%) |
Jun 2018 | - | $7.99M(+11.5%) |
Mar 2018 | - | $7.16M(+11.2%) |
Dec 2017 | $26.96M(-0.4%) | $6.44M(+5.8%) |
Sep 2017 | - | $6.09M(-9.8%) |
Jun 2017 | - | $6.75M(-12.0%) |
Mar 2017 | - | $7.67M(+7.3%) |
Dec 2016 | $27.07M(+194.3%) | $7.15M(-0.8%) |
Sep 2016 | - | $7.21M(+5.6%) |
Jun 2016 | - | $6.83M(+16.1%) |
Mar 2016 | - | $5.88M(+86.5%) |
Dec 2015 | $9.20M(+67.6%) | $3.15M(+55.9%) |
Sep 2015 | - | $2.02M(-2.9%) |
Jun 2015 | - | $2.08M(+7.8%) |
Mar 2015 | - | $1.93M(-0.8%) |
Dec 2014 | $5.49M(+198.4%) | $1.95M(+14.8%) |
Sep 2014 | - | $1.70M |
Dec 2013 | $1.84M | - |
FAQ
- What is Axsome Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Axsome Therapeutics?
- What is Axsome Therapeutics annual operating expenses year-on-year change?
- What is Axsome Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly operating expenses year-on-year change?
What is Axsome Therapeutics annual total operating expenses?
The current annual operating expenses of AXSM is $604.83M
What is the all time high annual operating expenses for Axsome Therapeutics?
Axsome Therapeutics all-time high annual total operating expenses is $604.83M
What is Axsome Therapeutics annual operating expenses year-on-year change?
Over the past year, AXSM annual total operating expenses has changed by +$177.39M (+41.50%)
What is Axsome Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of AXSM is $167.14M
What is the all time high quarterly operating expenses for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly total operating expenses is $169.88M
What is Axsome Therapeutics quarterly operating expenses year-on-year change?
Over the past year, AXSM quarterly total operating expenses has changed by +$29.75M (+21.66%)